García-Silva and colleagues demonstrated that melanoma-secreted EVs promote lymphangiogenesis and lymph node metastasis through the nerve growth factor (NGF) receptor (NGFR), which acts on lymphatic endothelial cells [85]. This evidence concerns the gene NGFR and melanoma.